Summary of Gastroesophageal Reflux Disease (GERD) Management
GERD Management: A Student's Guide to Reflux Relief
Introduction
Gastroesophageal reflux disease (GERD) occurs when gastric contents repeatedly reflux into the esophagus and cause troublesome symptoms or mucosal injury. Reflux is physiologic when brief and asymptomatic; it is GERD when symptoms impair quality of life or when objective esophageal injury (esophagitis, stricture, Barrett's esophagus) is present. This guide summarizes initial evaluation, lifestyle measures, empiric pharmacotherapy, and approaches to recurrent or persistent symptoms.
Definition: Gastroesophageal reflux disease (GERD) is the condition in which reflux of stomach contents produces bothersome symptoms and/or complications such as erosive esophagitis or Barrett's esophagus.
Core concepts broken down
Pathophysiology (bite-sized)
- The antireflux barrier includes the lower esophageal sphincter (LES), crural diaphragm, and normal anatomy of the gastroesophageal junction. Dysfunction allows reflux.
- Symptom generation depends on acid exposure plus esophageal sensitivity and central modulation (gut-brain axis).
- Factors increasing intra-abdominal pressure, gastric distention, or impairing clearance predispose to reflux.
When to perform upper endoscopy (practical rule)
- Most patients with typical heartburn/regurgitation do NOT need immediate endoscopy.
- Indications for initial endoscopy include (examples): alarm features (weight loss, GI bleeding, progressive dysphagia), new dyspepsia age ≥60, chronic GERD ≥5 years with multiple Barrett risk factors, imaging that shows luminal abnormality, and family history of GI cancer.
Definition: Alarm features are clinical signs that suggest a higher risk of serious disease such as malignancy; examples include unexplained weight loss, bleeding, progressive dysphagia, and iron-deficiency anemia.
History-focused assessment (how to tailor therapy)
- Categorize symptom frequency: intermittent (<2 episodes/week) or frequent (≥2 episodes/week).
- Assess severity by effect on quality of life.
- Ask about nocturnal symptoms, relation to meals (postprandial), patient-identified trigger foods/drinks, sleep position, recent weight change, clothing/garment tightness, tobacco and alcohol use, and medication list.
Counseling and lifestyle measures (practical, patient-centered)
- Explain the basics: GERD involves reflux plus individual symptom sensitivity; lifestyle changes can reduce reflux frequency/severity.
- Individualize the plan; avoid overly restrictive blanket diets. Use patient-identified triggers.
Key lifestyle and behavioral measures: (use as checklist)
- Weight loss if overweight or recent weight gain.
- Avoid large meals and stop eating ≥3 hours before lying down.
- Elevate head of bed (6–8 inch blocks or wedge); sleep on left lateral decubitus if nocturnal symptoms.
- Avoid tight garments around abdomen.
- Limit alcohol, carbonated beverages, excess coffee/caffeine, spicy/fatty fried foods, and peppermint if identified as triggers.
- Tobacco cessation.
- Encourage regular physical activity and diaphragmatic breathing exercises when regurgitation/rumination is prominent.
- Consider chewing gum or lozenges to stimulate salivation when appropriate.
Empiric pharmacotherapy — stepwise approach
Overview: choose therapy based on symptom frequency and severity and whether endoscopy has been performed.
Table: Initial choice by symptom pattern
| Clinical scenario | Initial approach | Notes |
|---|---|---|
| Mild, intermittent symptoms (<2/wk) | Step-up: lifestyle + as-needed antacids, alginates, or low-dose H2RA | Try 2–8 week trials; many respond without daily acid suppression |
| Frequent or severe symptoms (≥2/wk or QoL impairment) | Standard-dose PPI |
Sign up for the full summaryAlready have an account? Sign in
GERD Essentials
Klíčová slova: Gastroesophageal reflux disease, Conflicts of interest
Klíčové pojmy: GERD = reflux causing troublesome symptoms or esophageal injury, Most patients with typical heartburn/regurgitation do not require initial endoscopy, Classify symptoms as intermittent (<2/week) or frequent (≥2/week) to guide therapy, Lifestyle modifications (weight loss, meal timing, bed head elevation, trigger avoidance) are first-line for all patients, Mild/intermittent symptoms: step-up approach with antacids, alginates, or H2RAs trialed 2–8 weeks, Frequent/severe symptoms: start standard-dose PPI once daily 30–60 min before breakfast for 8 weeks, Vonoprazan (PCAB) is preferred for high-grade erosive esophagitis and is an alternative to PPIs, After response, continue 8 weeks then taper/discontinue for most patients; taper if >6 months therapy, Recurrent symptoms <3 months after stopping often require maintenance therapy, Refer patients with refractory symptoms, alarm features, or complicated disease for endoscopy and specialist evaluation